English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

The purpose of the study was to investigate the effect of eicosapentaenoic acid (c 20: 5, w 3; EPA) on the serum lipids and fatty acid profiles, platelet functions and coagulation systems. Highly concentrated (75 %) EPA ethylester, which was isolated and purified from sardine oil, was given to 17 patients suffering from hyperlipoproteinemia and/or hypertension for at least 16 weeks. Daily doses of EPA were 0.9g in 6, 1.8g in 7 and 2.7g in 4 patients. Initial mean total cholesterol level (TC) was 270.9+45.0mg/dl and reduction rates of TC were 4.4% at 4 week-period, 5.8% at 8 week-period, 3.1% at 16 week-period and 6.4% at 12 month-period of the treatment. Triglyceride level fell significantly, 20.9% at 4 week-period, 13.0% at 16 week-period and 18.6% at 12 month-period. HDL-cholesterol did not significantly change throughout the treatment. Changes in plasma main fatty acid profiles were shown in fig 1. plasma EPA increased from 1.84 mol % to 5.41 mol% after 4 weeks and 4.77 mol % after 16 weeks, while other polyunsaturated fatty acids except arachidonate inclined to decrease. Above all, plasma linoleate fell significantly after taking EPA. No correlation between ATG and Alinoleate suggests that exogenous EPA bound mainly to a-position of triglyceride

Effects of eicosapentaenoic acid on lipid metabolism including fatty acid profiles and on the coagulation